Free Trial

Agilent Technologies (A) Stock Price, News & Analysis

+1.05 (+0.79%)
(As of 06/12/2024 ET)
Today's Range
50-Day Range
52-Week Range
2.40 million shs
Average Volume
1.64 million shs
Market Capitalization
$38.85 billion
P/E Ratio
Dividend Yield
Price Target

Agilent Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
2.5% Upside
$136.50 Price Target
Short Interest
1.52% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.77mentions of Agilent Technologies in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$2.67 M Sold Last Quarter
Proj. Earnings Growth
From $5.25 to $5.83 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.08 out of 5 stars

Computer And Technology Sector

143rd out of 587 stocks

Analytical Instruments Industry

8th out of 28 stocks

A stock logo

About Agilent Technologies Stock (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock Price History

A Stock News Headlines

Padraig McDonnell Assumes Agilent CEO Role
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/24 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 7/24 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Analytical instruments
Life Sciences Tools & Services
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
16 Analysts


Net Income
$1.24 billion
Pretax Margin


Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$6.43 per share
Book Value
$21.30 per share


Free Float
Market Cap
$38.85 billion

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained


Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies, Inc. has shown consistent revenue growth over the past few quarters, indicating a strong financial performance.
  • The company's current stock price is stable and has been showing an upward trend, suggesting positive investor sentiment.
  • Agilent Technologies, Inc. has a diversified product portfolio, reducing dependency on any single product or market segment.
  • The company has a strong presence in the healthcare and life sciences industries, which are expected to grow significantly in the coming years.
  • Agilent Technologies, Inc. has a solid track record of innovation and product development, staying competitive in the market.


Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Agilent Technologies, Inc. operates in a highly competitive industry, which may lead to pricing pressures and reduced margins.
  • The company's stock valuation may be considered high compared to industry peers, posing a risk of overvaluation.
  • Agilent Technologies, Inc. is exposed to global economic conditions and geopolitical risks, impacting its international operations.
  • Fluctuations in raw material prices could affect the company's manufacturing costs and profitability.
  • Market volatility and regulatory changes in the healthcare sector could impact Agilent Technologies, Inc.'s business operations and financial performance.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, June 5, 2024. Please send any questions or comments about these Agilent Technologies pros and cons to

A Stock Analysis - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price target for 2024?

16 brokerages have issued 1 year target prices for Agilent Technologies' stock. Their A share price targets range from $90.00 to $155.00. On average, they anticipate the company's stock price to reach $136.50 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2024?

Agilent Technologies' stock was trading at $139.03 at the beginning of the year. Since then, A stock has decreased by 4.2% and is now trading at $133.16.
View the best growth stocks for 2024 here

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decrease in short interest in May. As of May 15th, there was short interest totaling 4,240,000 shares, a decrease of 9.8% from the April 30th total of 4,700,000 shares. Based on an average daily trading volume, of 1,540,000 shares, the short-interest ratio is currently 2.8 days. Approximately 1.5% of the company's shares are sold short.
View Agilent Technologies' Short Interest

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 20th 2024.
View our A earnings forecast

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) released its earnings results on Wednesday, May, 29th. The medical research company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.03. The medical research company earned $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a trailing twelve-month return on equity of 26.25% and a net margin of 18.84%. Agilent Technologies's revenue was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.27 EPS.
Read the conference call transcript

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, May 22nd. Shareholders of record on Tuesday, July 2nd will be given a dividend of $0.236 per share on Wednesday, July 24th. This represents a $0.94 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Tuesday, July 2nd.
Read our dividend analysis for A

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.94 per share and currently has a dividend yield of 0.71%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 16.12% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its board has authorized a stock repurchase program on Monday, January 9th 2023, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 4.4% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its third quarter 2024 earnings guidance on Wednesday, May, 29th. The company provided earnings per share (EPS) guidance of 1.250-1.280 for the period, compared to the consensus earnings per share estimate of 1.450. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.20%), Price T Rowe Associates Inc. MD (2.91%), Cantillon Capital Management LLC (1.22%), Principal Financial Group Inc. (0.96%), Nordea Investment Management AB (0.95%) and Van ECK Associates Corp (0.95%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Philip Binns and Rodney Gonsalves.
View institutional ownership trends

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
This page (NYSE:A) was last updated on 6/13/2024 by Staff

From Our Partners